Items where authors include "Arumugakani, G"

Article

Walker, K orcid.org/0000-0002-6694-2979, Mistry, A, Watson, CM et al. (9 more authors) (2023) Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12. Journal of Clinical Immunology, 43. pp. 1543-1556. ISSN 0271-9142

Denman, S, Smith, H, Arumugakani, G et al. (2 more authors) (2022) Cost effectiveness of personalised omalizumab dosing for chronic spontaneous urticaria. Clinical and Experimental Dermatology, 47 (11). pp. 2002-2005. ISSN 0307-6938

Abolhassani, H, El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Arumugakani, G et al. (12 more authors) (2020) Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency. Journal of Clinical Immunology, 40. pp. 277-288. ISSN 0271-9142

Whitworth, J, Smith, PS, Martin, J-E et al. (330 more authors) (2018) Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes. The American Journal of Human Genetics, 103 (1). pp. 3-18. ISSN 0002-9297

Lawless, D orcid.org/0000-0001-8496-3725, Mistry, A, Wood, PM et al. (7 more authors) (2017) Bialellic Mutations in Tetratricopeptide Repeat Domain 7A (TTC7A) Cause Common Variable Immunodeficiency-Like Phenotype with Enteropathy. Journal of Clinical Immunology, 37 (7). pp. 617-622. ISSN 0271-9142

Arumugakani, G, Stephenson, SJ, Newton, DJ orcid.org/0000-0002-0214-1486 et al. (5 more authors) (2017) Early emergence of CD19-negative human antibody secreting cells at the plasmablast to plasma cell transition. Journal of Immunology, 198 (12). pp. 4618-4628. ISSN 0022-1767

Cherukuri, A, Salama, AD, Carter, CR et al. (5 more authors) (2017) Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function. Kidney International, 91 (1). pp. 183-195. ISSN 0085-2538

Elkaim, E, Neven, B, Bruneau, J et al. (40 more authors) (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study. Journal of Allergy and Clinical Immunology, 138 (1). 210-218.e9. ISSN 0091-6749

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, Das, S et al. (5 more authors) (2015) Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Annals of the Rheumatic Diseases, 74 (9). pp. 1734-1738. ISSN 0003-4967

Arumugakani, G, Vital, EM, Md Yusof, MY et al. (2 more authors) (2014) Response to: 'Which B-cell subset should we target in lupus?' By Ferraccioli and Houssiau. Annals of the Rheumatic Diseases, 73 (4). e20. ISSN 0003-4967

Conference or Workshop Item

Corps, C, Denman, S, Ford, K et al. (5 more authors) (2017) Short course specific immunotherapy for seasonal allergic rhinoconjunctivitis and its impact on quality of life. In: European Academy of Allergy and Clinical Immunology Congress (EAACI 2017), 17-21 Jun 2017, Helsinki, Finland.

Denman, S, Toolan, J, Ford, K et al. (5 more authors) (2017) The impact of the introduction of icatibant on A&E attendance, hospital admissions and acute treatment episodes in patients with hereditary angioedema. In: European Academy of Allergy and Clinical Immunology Congress (EAACI 2017), 17-21 Jun 2017, Helsinki, Finland.

Proceedings Paper

Savic, L, Hopkins, P orcid.org/0000-0002-8127-1739, Ford, K et al. (2 more authors) (2019) Drug provocation testing (DPT) to exclude neuromuscular blocking agent (NMBA) allergy: a case report. In: Clinical and Experimental Allergy. BSACI Annual Meeting, 03-05 Oct 2019, Harrogate, UK. , p. 1664.